
Current Price | $4.40 | Mkt Cap | $314.4M |
---|---|---|---|
Open | $4.25 | P/E Ratio | 0.00 |
Prev. Close | $4.40 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.02 - $4.49 | Volume | 7,715,865 |
52-Wk Range | $2.87 - $32.68 | Avg. Daily Vol. | 7,907,422 |
Current Price | $4.40 | Mkt Cap | $314.4M |
---|---|---|---|
Open | $4.25 | P/E Ratio | 0.00 |
Prev. Close | $4.40 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.02 - $4.49 | Volume | 7,715,865 |
52-Wk Range | $2.87 - $32.68 | Avg. Daily Vol. | 7,907,422 |
The best Bull and Bear pitches based on recency and number of recommendations.
From Fidelity or Zacks December 2021:Revenue Growth (Last 5 Years) = 77.9%Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%Price/Sales (TTM) = 14.2Re-establishing this position at a lower price.
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Read the most recent pitches from players about BLUE.
Recs
From Fidelity or Zacks December 2021:
Revenue Growth (Last 5 Years) = 77.9%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 17.7%
Price/Sales (TTM) = 14.2
Re-establishing this position at a lower price.
Recs
Gene therapies will be a huge growth sector in health care in the next decade.
Recs
Weak pipeline, continued difficulty with commercialization, recently lost 100% of its C-suite, ongoing litigation, and more.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (< 20) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
secohen11 | 32.74 | 7/2/2013 |
![]() |
1Y | $26.20 | -83.61% | +141.17% | +224.78 | 0 Comment | |
saab93boi | < 20 | 6/19/2013 |
![]() |
5Y | $25.68 | -83.27% | +136.35% | +219.62 | 0 Comment | |
rwpaules | 87.35 | 6/19/2013 |
![]() |
3Y | $25.09 | -82.88% | +134.82% | +217.70 | 0 Comment | |
biotechf | 37.46 | 1/22/2016 |
![]() |
3M | $44.44 | -90.34% | +105.25% | +195.58 | 0 Comment | |
MotleyFolJohn | < 20 | 2/2/2015 |
![]() |
1Y | $93.98 | -95.43% | +94.60% | +190.03 | 1 Comment | |
![]() |
CommodityBuyer | < 20 | 7/10/2015 |
![]() |
5Y | $160.69 | -97.33% | +87.36% | +184.69 | 0 Comment |
pro64grammer | 28.28 | 12/9/2014 |
![]() |
5Y | $79.58 | -94.60% | +89.84% | +184.45 | 0 Comment | |
3rdChanceTom | 85.99 | 3/11/2016 |
![]() |
5Y | $45.77 | -90.62% | +93.07% | +183.69 | 0 Comment | |
cthomas1017 | 98.10 | 7/16/2014 |
![]() |
5Y | $31.85 | -86.51% | +96.66% | +183.17 | 0 Comment | |
coptermech66 | < 20 | 10/29/2015 |
![]() |
3Y | $79.54 | -94.60% | +86.09% | +180.69 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.